beta-D-Galp-(1->4)-[alpha-D-Glcp-(1->2)]-D-Glcp

Term ID

CHEBI:147953

Synonyms

(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5R)-4,6-dihydroxy-2-(hydroxymethyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
alpha-D-gluco-hexopyranosyl-(1->2)-[beta-D-galacto-hexopyranosyl-(1->4)]-D-gluco-hexopyranose
beta-D-galactopyranosyl-(1->4)-[alpha-D-glucopyranosyl-(1->2)]-D-glucopyranose
Glc(a1-2)[Gal(b1-4)]Glc
WURCS=2.0/3,3,2/[a2122h-1x_1-5][a2122h-1a_1-5][a2112h-1b_1-5]/1-2-3/a2-b1_a4-c1

Definition

A trisaccharide that is lactose in which the hydroxy group at position 2 has been converted into the corresponding alpha-D-glucopyranosyl derivative.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: trisaccharide

trisaccharide Show first 5 Terms
has_functional_parent: alpha-D-Glcp-(1->2)-D-Glcp lactose

alpha-D-Glcp-(1->2)-D-Glcp lactose Show first 5 Terms

Phenotype

Phenotype resulting from beta-D-Galp-(1->4)-[alpha-D-Glcp-(1->2)]-D-Glcp

Phenotype where environments contain beta-D-Galp-(1->4)-[alpha-D-Glcp-(1->2)]-D-Glcp

Phenotype modified by environments containing beta-D-Galp-(1->4)-[alpha-D-Glcp-(1->2)]-D-Glcp

Human Disease Model